Top 5 stocks in focus on August 17: Axis Bank, PSBs to AstraZeneca, here are the 5 newsmakers of the day
The Indian stock markets on Thursday closed in negative zone. Sensex shed 188 points and Nifty50 50 points. But, there were certain stocks that came in news due to certain reasons after the market was closed for trading for the day and can have an impact on the market after it is reopened for trading today, on August 17, 2018.
The Indian stock markets on Thursday closed in negative zone. Sensex shed 188 points and Nifty50 50 points. But, there were certain stocks that came in news due to certain reasons after the market was closed for trading for the day and can have an impact on the market after it is reopened for trading today, on August 17, 2018. Here is the list of five such stocks:
Axis Bank: The private lender has decided to sell 12 non-performing assets (NPAs) worth Rs 1,000 crore to Asset Reconstruction Company (ARC) by end of August 2018.
Public Sector Banks (PSBs): PSBs will remain in focus today because the government has asked the Reserve Bank of India (RBI) to consider diluting the Prompt Corrective Action (PCA) framework to ensure regulatory sanctions against PSBs are lifted swiftly. The framework was aimed at maintaining the sound financial health of banks.
Gati Ltd/Allcargo Logistics: Management of Gati in its clarification to BSE has said that Allcargo Logistics’ buyout plan has not been finalised and the company is still evaluating opportunities. In its filing to the exchange, the company said the news item is a rumour based information and hence the disclosure under the above Regulation does not arise to be made to the stock exchanges.
Watch this Zee Business video here:
Ratnamani Metals & Tubes: The company has announced that it has bagged orders aggregating to Rs 125 crore recently from GAIL for the supply of 24-inch diameter pipes for the 108km long Barauni—Guwahati segment of the Jagdishpur—Haldia & Bokaro-Dhamra Natural Gas Pipeline (JHBDPL) project.
AstraZeneca Pharma: The Pharmaceutical company has received import and market permission from the Drugs Controller General of India for Olaparib Tablets 100 mg and 150 mg (Lynparza). Olaparib tablets are used for the treatment of ovarian and breast cancer.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Power of Compounding: How soon will monthly SIP of Rs 6,000, Rs 8,000, and Rs 10,000 reach Rs 5 crore corpus target?
Highest FD rates: Here's what SBI, PNB, Canara Bank, HDFC Bank, ICICI Bank are giving to senior citizens on fixed deposits
Top 7 SBI Mutual Funds With Highest SIP Returns in 5 Years: Rs 15,000 monthly SIP investment in No. 1 scheme has grown to Rs 21,88,409; what about others?
SIP+SWP: Rs 10,000 monthly SIP for 20 years, Rs 25 lakh lump sum investment, then Rs 2.15 lakh monthly income for 25 years; see expert calculations
10:28 AM IST